Tag Archives: Chrisi Vlachou

Τόμος 34 (2020) – Τεύχος 1 –Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 1 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Τόμος 34 (2020) – Τεύχος 1 –Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 1 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Diabetic neuropathy (DNU) and nephropathy (DNP) are frequent diabetes mellitus (DM) complications, and incidence increases with diabetes duration: patients with DM for 20 years have 90% probability for DNU and 40% for DNP.
Continue reading →

Τόμος 36 (2022) – Τεύχος 1 – Άρθρο 2 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 36 (2022) – Issue 1 – Article 2 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Τόμος 36 (2022) – Τεύχος 1 – Άρθρο 2 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 36 (2022) – Issue 1 – Article 2 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Case study of a patient family with multiple endocrine neoplasia syndrome. Evaluation of Stress levels Continue reading →

Volume 37 (2023) – Issue 2 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Menu, Menu International, Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Volume 37 (2023) – Issue 2 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Cardiovascular diseases (CVDs) remain a significant global health concern, contributing to substantial morbidity and mortality.
Continue reading →

Volume 37 (2023) – Issue 2 – Article 2– Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Menu, Menu International, Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Volume 37 (2023) – Issue 2 – Article 2– Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The global COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. Vulnerable populations, such as individuals with underlying health conditions, are particularly at risk. Continue reading →

Τόμος 36 (2022) – Τεύχος 2-3 –Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 36 (2022) – Issue 2-3 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Τόμος 36 (2022) – Τεύχος 2-3 –Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 36 (2022) – Issue 2-3 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Since attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are typically seen as disorders with early onset, the majority of research has placed a strong emphasis on those children Continue reading →

Τόμος 36 (2022) – Τεύχος 2-3 –Άρθρο 2 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 36 (2022) – Issue 2-3 – Article 2 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Comments Off on Τόμος 36 (2022) – Τεύχος 2-3 –Άρθρο 2 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 36 (2022) – Issue 2-3 – Article 2 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Sotos Syndrome: An assessment of stress levels of the patient and the family. The response to disability and developmental diversity Continue reading →